Key Statistics
Market Cap$1.37B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.46
52W High$25.77
52W Low$3.50
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees150
Price Performance
1 Week+11.12%
3 Month+18.68%
1 Year+339.33%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$303.75M
Liabilities$124.50M
Net Income$135.35M loss
About
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new precision small molecule drugs that employ the body's natural mechanisms to selectively break down therapeutically relevant proteins. The company is headquartered in Boston, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze GLUE with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.